Irreversible inhibition of forskolin interactions with type I adenylyl cyclase by a 6-isothiocyanate derivative of forskolin

Molecular Pharmacology

Volumn 50, Issue 2, 1996, Pages 299-305

  Sutkowski, Elizabeth Mchugh ^a   Robbins, Joan D ^a   Tang, Wei Jen ^b   Seamon, Kenneth B ^a,c  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; FORSKOLIN; ISOTHIOCYANIC ACID DERIVATIVE;

ANIMAL CELL; ARTICLE; BINDING SITE; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBUNIT; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; THROMBOCYTE MEMBRANE;

ADENYLATE CYCLASE; AFFINITY LABELS; ANIMALS; BINDING SITES; DITHIOTHREITOL; ENZYME ACTIVATION; FORSKOLIN; ISOTHIOCYANATES; SPODOPTERA;

EID: 0029789944     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Seamon, K. B., and J. W. Daly. Forskolin: its biological and chemical properties. Adv. Cyclic Nucl. Prot. Phosph. Res. 20:1-150 (1986).
2. Seamon, K. B., and J. W. Daly. Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein. J. Biol. Chem. 256:9799-9801 (1981).
3. Green, D. A., and R. B. Clark. Direct evidence for the role of the coupling proteins in forskolin activation of adenylate cyclase. J. Cyclic Nucl. Res. 8:337-346 (1982).
4. Bender, J. L., and E. J. Neer. Properties of the adenylate cyclase unit from caudate nucleus. J. Biol. Chem. 258:2432-2439 (1983).
5. Krupinski, J., F. Coussen, H. A. Bakalyar, W.-J. Tang, P. G. Feinstein, K. Orth, C. Slaughter, R. R. Reed, and A. G. Gilman. Adenylyl cyclase amino acid sequence: possible channel- or transporter-like structure. Science (Washington D. C) 244:1558-1564 (1989).
6. Bakalyar, H. A., and R. R. Reed. Identification of a specialized adenylyl cyclase that may mediate odorant detection. Science (Washington D. C.) 250:1403-1406 (1990).
7. Tang, W.-J., J. Krupinski, and A. G. Gilman. Expression and characterization of calmodulin-activated (type I) adenylylcyclase. J. Biol. Chem. 266:8595-8603 (1991).
8. 2+/calmodulin-insensitive adenylyl cyclase from rat brain. Proc. Natl. Acad. Sci. USA 88:10173-10177 (1991).
9. Gao, B., and A. G. Gilman. Cloning and expression of a widely distributed (type IV) adenylyl cyclase. Proc. Natl. Acad. Sci. USA 88:10178-10182 (1991).
10. Ishikawa, Y., S. Katsushika, L. Chen, N. J. Halnon, J.-I. Kawabe, and C. J. Homcy. Isolation and characterization of a novel cardiac adenylylcyclase cDNA. J. Biol. Chem. 267:13553-13557 (1992).
11. 2+-inhibitable adenylyl cyclase from NCB-20 cells. Proc. Natl. Acad. Sci. USA 89:6716-6720 (1992).
12. Katsushika, S., L. Chen, J.-I. Kawabe, R. Nilakantan, N. J. Halnon, C. J. Homey, and Y. Ishikawa. Cloning and characterization of a sixth adenylyl cyclase isoform: types V and VI constitute a subgroup within the mammalian adenylyl cyclase family. Proc. Natl. Acad. Sci. USA 89:8774-8778 (1992).
13. Premont, R. T., J. Chen, H.-W. Ma, M. Ponnapalli, and R. Iyengar. Two members of a widely expressed subfamily of hormone-stimulated adenylyl cyclases. Proc. Natl. Acad. Sci. USA 89:9809-9813 (1992).
14. Cali, J. J., J. C. Zwaagstra, N. Mons, D. M. F. Cooper, and J. Krupinski. Type VIII adenylyl cyclase. J. Biol. Chem. 269:12190-12195 (1994).
15. Watson, P. A., J. Krupinski, A. M. Kempinski, and C. D. Frankenfeld. Molecular cloning and characterization of the type VII isoform of mammalian adenylyl cyclase expressed widely in mouse tissues and in S49 mouse lymphoma cells. J. Biol. Chem. 269:28893-28898 (1994).
16. Paterson, J. M., S. M. Smith, A. J. Harmar, and F. A. Antoni. Control of a novel adenylyl cyclase by calcineurin. Biochem. Biophys. Res. Commun. 214:1000-1008 (1995).
17. Bα. Biochemistry 33:12852-12859 (1994).
18. Taussig, R., W.-J. Tang, J. R. Hepler, and A. G. Gilman. Distinct patterns of bidirectional regulation of mammalian adenylyl cyclases. J. Biol. Chem. 269:6093-6100 (1994).
19. Tang, W.-J., and A. G. Gilman. Type-specific regulation of adenylyl cyclase by G protein βγ subunits. Science (Washington D. C.) 254:1500-1503 (1991).
20. 3H]forskolin to rat brain membranes. Proc. Natl. Acad. Sci. USA 81:5081-5085 (1984).
21. 3H]forskolin. Methods Enzymol. 195:52-65 (1991).
22. Robbins, J. D., A. Laurenza, R. W. Kosley, Jr., G. J. O'Malley, B. Spahl, and K. B. Seamon. (Aminoalkyl)carbamates of forskolin: intermediates for the synthesis of functionalized derivatives of forskolin with different specificities for adenylyl cyclase and the glucose transporter. J. Med. Chem. 34:3204-3212 (1991).
23. Laurenza, A., J. D. Robbins, and K. B. Seamon. Interaction of aminoalkyl-carbamates of forskolin with adenylyl cyclase: synthesis of an iodinated derivative of forskolin with high affinity for adenylyl cyclase. Mol. Pharmacol. 41:360-368 (1992).
24. Laurenza, A., Y. Khandelwal, N. J. De Souza, R. H. Rupp, H. Metzger, and K. B. Seamon. Stimulation of adenylate cyclase by water-soluble analogues of forskolin. Mol. Pharmacol. 32:133-139 (1987).
25. 1. FEBS Lett. 183:349-352 (1985).
26. 3H]forskolin to human platelet membranes. J. Biol. Chem. 261:13469-13473 (1986).
27. 3H]forskolin binding sites in human platelets by α-haloacetyl analogs of forskolin. Mol. Pharmacol. 37:69-74 (1990).
28. Morris, D. I., J. D. Robbins, A. E. Ruoho, E. M. Sutkowski, and K. B. Seamon. Forskolin photoaffinity labels with specificity for adenylyl cyclase and the glucose transporter. J. Biol. Chem. 266:13377-13384 (1991).
29. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254 (1976).
30. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.) 227:680-685 (1970).
31. Munson, P. J., and D. Rodbard. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:220-239 (1980).
32. 32P-labeled nucleoside triphosphates, nicotinamide adenine dinucleotide, and cyclic nucleotides for use in determining adenylyl and guanyl cyclases and cyclic nucleotide phosphodiesterase. Methods Enzymol. 195:29-44 (1991).
33. Sutkowski, E. M., F. Maher, A. Laurenza, I. A. Simpson, and K. B. Seamon. Interaction of 7-bromoacetyl-7-desacetylforskolin, an alkylating derivative of forskolin, with bovine brain adenylyl cyclase and human erythrocyte glucose transporter. Biochemistry 32:2415-2422 (1993).
34. Awad, J. A., R. A. Johnson, K. H. Jakobs, and G. Schultz. Interactions of forskolin and adenylate cyclase. J. Biol. Chem. 258:2960-2965 (1983)
35. Fothergill-Gilmore, L. A., and P. A. M. Michels. Evolution of glycolysis. Prog. Biophys. Mol. Biol. 59:105-235 (1993).
36. Tang, W.-J., M. Stanzel, and A. G. Gilman. Truncation and alanine-scanning mutants of type I adenylyl cyclase. Biochemistry 34:14563-14572 (1995).
37. Schulz, G. E. Domain motions in proteins. Curr. Opin. Struct. Biol. 1:883-888 (1991).
38. 8α and forskolin. Science (Washington D. C.) 268:1769-1772 (1995).